GENETIC NETWORKS, LLC

Lobbying Spend

—

Filings

Firms Hired

Active Period

2020–2024

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2024	—	3	1
2023	—	4	1
2022	—	4	1
2021	—	4	1
2020	—	3	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
AMERICAN DEFENSE INTERNATIONAL INC	—	18

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	15
SENATE	6
Defense, Dept of (DOD)	3
Executive Office of the President (EOP)	2

Most frequently reported lobbying issues

Issue Code	Description	Reports
Defense	Defense	16
Health Issues	Health Issues	5

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 2670118th Congress

National Defense Authorization Act for Fiscal Year 2024

Cited source text and reported amounts

H.R. 2670: National Defense Authorization Act (NDAA), provisions related to drug research

Client expense: — · Firm income: —

Matched citations: H.R. 2670

GENETIC NETWORKS, LLC — Lobbying Disclosure | Poliscope